11 a.m.

Pathology Department and Cell Culture Center at Eastern Hospital.

Zhao Heng stood in front of the biological equipment suitable for cell culture, frowning.

Pathology attending physician Qu Xiaofeng noticed Zhao Heng's frown and couldn't help but say, "Dr. Zhao, these are already the best cell culture equipment in the hospital."

Eastern Hospital hasn't established a dedicated cell culture center. The few cell culture devices available are placed in the pathology department and managed by them since they often conduct cell slide examinations, which somewhat relates.

But the equipment here is clearly not just a notch below Professor Li Hongwei's lab at Yanjing University School of Life Sciences.

That is understandable. One is a hospital, and the other is a top national biological laboratory, so the difference in equipment is naturally expected.

"Dr. Qu, how many years ago were these devices purchased?"

Zhao Heng asked Qu Xiaofeng.

"I think it was five years ago when stem cell treatment just started gaining momentum. So the hospital bought these devices, but later no one specialized in this research, so the equipment became idle."

Qu Xiaofeng thought for a bit and said.

Five years ago was when the concept of stem cell treatment first emerged. At that time, nearly every top hospital in the country was eager to venture into this emerging field, and Eastern Hospital was no exception, so they invested heavily in buying this imported equipment.

"Dr. Zhao, these devices should still be okay, right? I heard the hospital spent nearly thirty million on them five years ago."

Seeing Zhao Heng's somewhat dissatisfied expression, Qu Xiaofeng couldn't help but say.

Thirty million, although not a crippling amount for a top hospital, is still a significant investment.

Actually, the equipment in top hospitals is very expensive. For example, an imported MRI, even just the standard 1.5T version, costs at least ten million.

But if it's the 3.0T and high-field MRI equipment with core technology controlled abroad, it would cost thirty to fifty million.

Calculating like this, an investment of thirty million isn't too high.

Therefore, these devices are only capable of basic stem cell research, and for more profound research, relying solely on equipment of this level isn't feasible.

Conducting scientific research is very costly. For instance, Professor Li Hongwei's annual research funding is at least in the hundreds of millions.

"No matter how good the equipment is, after five years, it's a bit outdated, but still usable."

Zhao Heng pondered and said. The equipment for cellular research at Eastern Hospital naturally couldn't compare to Professor Li Hongwei's lab at Yanjing University School of Life Sciences.

Zhao Heng, having absorbed Professor Li Hongwei's experience and worked with him in Lab 1 for quite some time, had become accustomed to the high-end instruments at the Yanjing University lab. So using the relatively one-generational lagging equipment at Eastern Hospital could make it a bit hard to adjust.

Forget it, just as a mother doesn't dislike her ugly son or a dog its poor home, after all, these devices bought for tens of millions, although incomparable to the billion-worth equipment at Professor Li Hongwei's side, are at least usable.

If these devices weren't available, Zhao Heng would have to borrow a lab, which would be even more costly.

The fact that Eastern Hospital even has these devices was already beyond Zhao Heng's expectations.

"Dr. Zhao, what project are you working on this time? Is it still stem cell culture?"

Qu Xiaofeng asked with great interest.

Since Zhao Heng invited Professor Li Hongwei and successfully treated Sun Xinxin using neural stem cell therapy, a significant number of doctors have become interested in stem cell therapy, including Qu Xiaofeng.

Moreover, being a pathologist who frequently deals with cells, naturally, he's interested in understanding this very advanced and cutting-edge treatment approach of stem cell therapy.

Thinking about it, if he could master this stem cell treatment technique, his status in the hospital would rise significantly, possibly being more than just a pathologist spending every day with a microscope.

"This time it's about somatic cell proliferation and culture."

Zhao Heng said.

"Somatic cell proliferation and culture? For what purpose?"

Seeing that Zhao Heng was not doing stem cell culture, Qu Xiaofeng became more interested. Did Zhao Heng also grasp other techniques?

Since Zhao Heng had followed Professor Li Hongwei for a period, everyone in the hospital believed Zhao Heng must have learned Professor Li's core technologies, so naturally, more people wanted to learn from Zhao Heng.

But this opportunity was seized by Qu Xiaofeng first.

"This time it's about tumor biological therapy, primarily proliferating immune cells outside the body to reintroduce them and suppress tumor growth. This is a branch technique in Cell Fate Regulation."

Zhao Heng explained.

"Tumor biological therapy? That's also a very new treatment method, isn't it? I've heard there are only a few hospitals nationwide doing this."

Hearing this, Qu Xiaofeng said, somewhat surprised.

This Zhao Heng always manages to do something very surprising and has a pioneering spirit.

Whether it's spinal canal analgesia device implantation, brain function recovery using neural stem cells, or now tumor biological therapy, Zhao Heng seems to always have insightful ideas, not adhering to conventional ways but being very innovative and exploratory.

"Yes, recently I took on a patient with a primitive neuroectoderm tumor growing very rapidly in the orbital area. Without a way to suppress the tumor growth or shrink it, radical surgery isn't possible."

Zhao Heng explained once again.

Qu Xiaofeng is still a very good person. Strictly speaking, these devices fall under pathology management, but now that Zhao Heng needs to use them, Qu is very cooperative.

This gesture of mutual benefit naturally led Zhao Heng to share more with Qu.

"Primitive neuroectodermal tumor? That type of tumor is very aggressive."

Hearing Zhao Heng say this, Qu Xiaofeng remarked somewhat surprised.

Is Zhao Heng starting to challenge the impossible again?!

As a senior attending pathologist, what Qu Xiaofeng does daily is make various cell slides, then diagnose and report on various tumors. His understanding of tumors is second to none at Eastern Hospital.

Just because of his understanding of tumors, he knows that primitive neuroectodermal tumors are very aggressive and progress rapidly. At least from what he's heard, no one afflicted with this tumor has survived for more than a year.

"I'll give it my best shot."

Zhao Heng said steadily.

If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.